GO:0033138 positive regulation of peptidyl-serine phosphorylation: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033138 describes any process that increases the frequency, rate, or extent of serine phosphorylation on target proteins.
• Serine phosphorylation is a central post-translational modification that controls signal transduction, cell cycle progression, and stress responses.
• Dysregulation of this process is implicated in major depressive disorder and other neuropsychiatric conditions.
• Viral infections, including SARS-CoV-2, can modulate host serine phosphorylation to promote replication.
• Cancer progression, such as pancreatic adenocarcinoma, is linked to altered phosphorylation signaling and m6A methylation regulators.
• CRISPR-based knockout, knock-in, and point-mutation models are essential to dissect causal roles of kinases and phosphatases in this process.
Description
GO:0033138, positive regulation of peptidyl-serine phosphorylation, is a biological process term that captures any molecular event that activates or increases the addition of phosphate groups to serine residues on proteins. This modification is one of the most abundant post-translational modifications in eukaryotic cells and serves as a molecular switch in nearly every signaling pathway, from growth factor reception to cell cycle checkpoints. Researchers study this term because serine phosphorylation dynamics are frequently altered in disease states, including depression, viral infection, and cancer. Understanding the positive regulators of this process, such as kinases and scaffolding proteins, provides mechanistic insight into both normal physiology and pathological signaling. The term is deliberately broad, encompassing direct kinase activation, inhibition of phosphatases, and changes in substrate accessibility, making it a hub for systems-level analysis.
positive regulation of peptidyl-serine phosphorylation At A Glance
| GO ID | GO:0033138 |
|---|---|
| GO term | positive regulation of peptidyl-serine phosphorylation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Upregulation of serine phosphorylation on target proteins |
| Related processes | Signal transduction, cell cycle, stress response, apoptosis |
| Disease relevance | Depression, viral infection, pancreatic adenocarcinoma |
| Key regulators | Kinases (e.g., AKT, MAPK), phosphatases (e.g., PP2A), scaffold proteins |
What Is GO:0033138?
In our own words, GO:0033138 refers to any biological process that enhances the phosphorylation of serine residues within peptides or proteins. This includes the activation of serine/threonine kinases, the suppression of serine phosphatases, and the recruitment of substrates or cofactors that favor phosphate transfer to serine. The term does not describe the phosphorylation event itself, but rather the regulatory inputs that increase its occurrence or magnitude.
Why Is positive regulation of peptidyl-serine phosphorylation Important in Cell Biology?
Positive regulation of peptidyl-serine phosphorylation is a fundamental control point in cellular signaling because it determines how quickly and robustly cells respond to external and internal cues. Many kinases that drive this process are drug targets, and their dysregulation contributes to cancer, neurodegeneration, and infectious diseases. For researchers, mapping the positive regulators of serine phosphorylation is essential to understand disease mechanisms and to identify therapeutic vulnerabilities.
• Controls signal transduction cascades downstream of growth factor receptors.
• Regulates cell cycle progression and checkpoint activation.
• Modulates stress responses and apoptosis.
• Implicated in major depressive disorder through molecular mechanisms involving heavy metals.
• Influenced by viral infections, including SARS-CoV-2, which hijack host phosphorylation machinery.
• Associated with cancer progression, such as pancreatic adenocarcinoma, via m6A methylation regulators.
• Provides targets for kinase inhibitor drug discovery.
• Essential for immune cell activation and cytokine production.
• Key to understanding neurodevelopmental and neurodegenerative disorders.
• Enables systems-level modeling of signaling networks.
What Happens During positive regulation of peptidyl-serine phosphorylation?
Kinase activation and substrate recognition
In simple terms: Kinases are enzymes that add phosphate groups to serine residues, and their activation is the first step in this process.
Positive regulation often begins with the activation of serine/threonine kinases through phosphorylation, second messenger binding, or protein-protein interactions. For example, growth factor signaling can activate AKT, which then phosphorylates serine residues on downstream targets. This step is tightly controlled by upstream receptors and adaptor proteins, ensuring that phosphorylation occurs only when appropriate.
Phosphatase inhibition
In simple terms: Phosphatases remove phosphate groups, so blocking them increases serine phosphorylation.
Another mechanism of positive regulation is the inhibition or downregulation of serine phosphatases such as PP2A. When phosphatases are suppressed, the net level of serine phosphorylation increases even without additional kinase activity. This mode of regulation is common in stress responses and can be triggered by viral proteins that sequester phosphatases.
Scaffold and adaptor protein recruitment
In simple terms: Scaffold proteins bring kinases and substrates together, making phosphorylation more efficient.
Scaffold proteins such as AKAPs and 14-3-3 proteins physically bridge kinases and their substrates, enhancing the rate and specificity of serine phosphorylation. Their recruitment is a key positive regulatory event that can be modulated by cellular signals, including those activated during viral infection.
Substrate availability and conformational changes
In simple terms: Changing a protein's shape can expose serine residues, making them easier to phosphorylate.
Post-translational modifications or binding partners can induce conformational changes that expose previously buried serine residues, increasing their accessibility to kinases. This mechanism is particularly relevant in cancer, where mutations in oncogenes can lock proteins in a conformation that favors phosphorylation.
Feedback loops and signal amplification
In simple terms: Once started, phosphorylation can trigger more phosphorylation, creating a cascade.
Positive regulation often involves feed-forward loops where an initial phosphorylation event activates a kinase that phosphorylates additional substrates, amplifying the signal. Such amplification is critical for switch-like cellular decisions, including cell cycle entry and apoptosis.
Key Genes Involved in GO:0033138 positive regulation of peptidyl-serine phosphorylation
The following genes and proteins are central to the positive regulation of peptidyl-serine phosphorylation, based on their roles in signaling, disease, and experimental models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AKT1 | Serine/threonine kinase that phosphorylates many substrates | Cancer, depression, viral infection |
| MAPK1 | Kinase in growth factor signaling | Cell proliferation, cancer |
| MAPK3 | Kinase in growth factor signaling | Cell proliferation, cancer |
| MTOR | Kinase that integrates nutrient and growth signals | Cancer, neurodegeneration |
| PIK3CA | Catalytic subunit of PI3K, activates AKT | Cancer, depression |
| PPP2CA | Phosphatase that removes serine phosphates | Cancer, viral infection |
| RBM15 | m6A methylation regulator, affects phosphorylation signaling | Pancreatic adenocarcinoma |
| GSK3B | Kinase involved in multiple signaling pathways | Depression, cancer |
| CDK1 | Cell cycle kinase | Cancer, cell cycle research |
| CDK2 | Cell cycle kinase | Cancer, cell cycle research |
| PRKACA | cAMP-dependent protein kinase | Metabolism, depression |
| CHEK1 | Checkpoint kinase | DNA damage response, cancer |
| ATM | DNA damage kinase | Cancer, neurodegeneration |
| SRC | Non-receptor tyrosine kinase, also affects serine phosphorylation | Cancer, viral infection |
| JAK2 | Janus kinase, activates STAT proteins | Immune signaling, viral infection |
| STAT3 | Transcription factor activated by serine phosphorylation | Cancer, inflammation |
How Is positive regulation of peptidyl-serine phosphorylation Regulated?
The positive regulation of peptidyl-serine phosphorylation is itself regulated by upstream signals such as growth factors, hormones, and stress stimuli. Key regulatory nodes include the PI3K/AKT/mTOR pathway, which promotes serine phosphorylation of many substrates, and the MAPK cascade, which amplifies phosphorylation signals. In viral infections, viral proteins can directly or indirectly enhance host serine phosphorylation to favor replication. In cancer, mutations in oncogenes like PIK3CA or RBM15 can constitutively activate phosphorylation pathways.
positive regulation of peptidyl-serine phosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKT1 | Major depressive disorder, cancer | Knockout mice, point-mutation cell lines |
| RBM15 | Pancreatic adenocarcinoma | Knockdown and overexpression in pancreatic cancer cells |
| PPP2CA | Viral infection, cancer | CRISPR knockout in viral infection models |
| PIK3CA | Cancer, depression | Knock-in mutations in cell lines |
| MAPK1 | Cancer, neuropsychiatric disorders | Conditional knockout mice |
Neuropsychiatric disorders
Dysregulation of serine phosphorylation is implicated in major depressive disorder, where exposure to heavy metals such as cadmium, lead, mercury, and arsenic alters molecular mechanisms involving phosphorylation signaling. These changes can affect neurotransmitter release and synaptic plasticity, contributing to depression pathogenesis.
Viral infections
SARS-CoV-2 and other viruses modulate host serine phosphorylation to promote their replication and evade immune responses. Traditional medicinal plants from Ayurveda have shown antiviral activity partly by interfering with these phosphorylation events.
Cancer
In pancreatic adenocarcinoma, the m6A methylation regulator RBM15 promotes cell proliferation and is associated with altered phosphorylation signaling. Positive regulation of serine phosphorylation can drive oncogenic pathways, making it a target for therapeutic intervention.
From positive regulation of peptidyl-serine phosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does kinase X positively regulate serine phosphorylation of substrate Y? | CRISPR knockout of kinase X followed by phospho-specific western blot |
| What is the effect of a disease-associated point mutation in a kinase? | Point-mutation knock-in cell lines |
| Can a phosphatase inhibitor enhance serine phosphorylation? | Overexpression of phosphatase inhibitor or CRISPR activation |
| Which genes regulate serine phosphorylation in a genome-wide manner? | CRISPR library screening with phospho-antibody readout |
| How does viral infection alter host serine phosphorylation? | Knockout of viral proteins in infected cells |
| What is the role of RBM15 in pancreatic cancer phosphorylation? | RBM15 knockout and overexpression in pancreatic cancer cells |
How to Study the positive regulation of peptidyl-serine phosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-specific western blot | Levels of specific serine phosphorylation | Validation of kinase activation |
| Phosphoproteomics | Global serine phosphorylation sites | Systems-level signaling studies |
| CRISPR knockout screen | Genes that regulate phosphorylation | Discovery of novel regulators |
| Kinase activity assay | Enzymatic rate of serine phosphorylation | Drug discovery and mechanism |
| Immunofluorescence | Subcellular localization of phospho-proteins | Spatial regulation studies |
| Co-immunoprecipitation | Protein-protein interactions | Identification of kinase-substrate complexes |
| RNA-seq | Transcriptional changes after perturbation | Pathway analysis |
| Proximity ligation assay | In situ detection of phosphorylation events | Single-cell analysis |
Phospho-specific western blotting
This method uses antibodies that recognize phosphorylated serine residues on specific proteins to quantify changes in phosphorylation levels after genetic or pharmacological perturbations.
Mass spectrometry-based phosphoproteomics
Large-scale identification and quantification of serine phosphorylation sites across the proteome, enabling systems-level analysis of positive regulation.
CRISPR screening with phospho-readouts
Genome-wide CRISPR knockout or activation screens coupled with phospho-specific antibodies or mass spectrometry to identify regulators of serine phosphorylation.
Kinase activity assays
In vitro assays using recombinant kinases and substrates to measure the direct effect of positive regulators on serine phosphorylation.
How CRISPR Can Be Used to Study GO:0033138 positive regulation of peptidyl-serine phosphorylation
Knockout
CRISPR knockout of kinases or phosphatases can abolish or enhance serine phosphorylation, allowing researchers to test causality. For example, knocking out AKT1 reduces phosphorylation of its substrates, while knocking out PPP2CA increases basal serine phosphorylation.
Point Mutation
Introducing point mutations that alter kinase activity or substrate recognition sites can mimic disease-associated variants. This approach is useful for studying how specific mutations in genes like PIK3CA affect serine phosphorylation dynamics.
Knock-in
Knock-in of tagged or reporter versions of kinases allows real-time monitoring of their activity and localization. This can reveal how positive regulators are recruited to substrates in live cells.
Overexpression
Overexpressing a kinase or a positive regulator can drive excessive serine phosphorylation, modeling oncogenic signaling. This is particularly relevant for cancer research, where overexpression of RBM15 promotes proliferation.
How EDITGENE Supports positive regulation of peptidyl-serine phosphorylation Research
Researchers studying positive regulation of peptidyl-serine phosphorylation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of peptidyl-serine phosphorylation research.
Frequently Asked Questions About positive regulation of peptidyl-serine phosphorylation
What is GO:0033138?
GO:0033138 is the Gene Ontology term for positive regulation of peptidyl-serine phosphorylation, describing any process that increases the addition of phosphate groups to serine residues on proteins.
What genes are involved in positive regulation of peptidyl-serine phosphorylation?
Key genes include AKT1, MAPK1, MAPK3, MTOR, PIK3CA, PPP2CA, and RBM15, among others.
How is peptidyl-serine phosphorylation regulated?
It is regulated by kinase activation, phosphatase inhibition, scaffold protein recruitment, and substrate conformational changes.
What diseases are associated with dysregulated serine phosphorylation?
Diseases include major depressive disorder, viral infections such as SARS-CoV-2, and pancreatic adenocarcinoma.
What methods are used to study positive regulation of peptidyl-serine phosphorylation?
Common methods include phospho-specific western blotting, phosphoproteomics, CRISPR screens, and kinase activity assays.
Can CRISPR be used to study this process?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect causal roles of genes in serine phosphorylation.
What is the role of RBM15 in serine phosphorylation?
RBM15 is an m6A methylation regulator that promotes cell proliferation in pancreatic adenocarcinoma and is associated with altered phosphorylation signaling.
How do viruses affect host serine phosphorylation?
Viruses like SARS-CoV-2 can modulate host serine phosphorylation to enhance replication and evade immune responses.
What is the connection between heavy metals and serine phosphorylation in depression?
Heavy metals such as cadmium, lead, mercury, and arsenic can alter molecular mechanisms involving phosphorylation signaling, contributing to depression.
What cell models are available for studying serine phosphorylation?
EDITGENE offers knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics services.
Conclusion
GO:0033138, positive regulation of peptidyl-serine phosphorylation, is a critical biological process that governs cellular signaling, disease pathogenesis, and therapeutic responses. Understanding its regulators and mechanisms requires robust experimental models, and CRISPR-based approaches are indispensable for causal inference. By leveraging EDITGENE's services, researchers can accelerate discoveries in this important area.
References
- 1. Nguyen HD et al.. 2023. Interactions between cadmium, lead, mercury, and arsenic and depression: A molecular mechanism involved.. J Affect Disord 327:315-329 PMID: 36758875
- 2. Maurya VK et al.. 2022. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection.. J Biomol Struct Dyn 40(4):1719-1735 PMID: 33073699
- 3. Zhao Z et al.. 2022. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.. Front Mol Biosci 9:842833 PMID: 35223996
